Shinozaki, Masayoshi
Saito, Daiki
Nakada, Taka-aki
Nomura, Yukihiro
Nakaguchi, Toshiya
Article History
Received: 22 August 2023
Accepted: 31 December 2023
First Online: 20 February 2024
Declarations
:
: Taka-aki Nakada received executive compensation from Smart119 and held stock. Inc. Taka-aki Nakada has a patent related to CRT measurements. Yukihiro Nomura belongs to an endowment department sponsored by HIMEDIC Inc. and Siemens Healthcare K.K.; however, the status is irrelevant to the contents of the paper. The remaining authors have no other conflicts of interest related to this submission.
: The Institutional Review Board of Chiba University Graduate School of Medicine approved this experimental study (approval number 4154).
: Informed consent was obtained from all subjects involved in the study.